SCHEMBL30833904 — predicted protein targets

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	NLRP3	Q96P20	10/20	0.38

▸	CCNK	O75909	1/20	0.33

▸	CDK7	P50613	1/20	0.33

▸	CCNH	P51946	1/20	0.33

▸	MNAT1	P51948	1/20	0.33

▸	CDK12	Q9NYV4	1/20	0.33

▸	ROCK2	O75116	1/20	0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30833913	0.91	CCNK (0.34)	NLRP3CCNKCDK7CCNHMNAT1
SCHEMBL29030501	0.90	NLRP3 (0.41)	NLRP3
SCHEMBL29030496	0.90	NLRP3 (0.41)	NLRP3
SCHEMBL30833888	0.90	NLRP3 (0.45)	NLRP3CCNKCDK12ROCK2
SCHEMBL30833882	0.88	NLRP3 (0.38)	NLRP3
SCHEMBL30833891	0.87	NLRP3 (0.54)	NLRP3CCNKCDK12ROCK2
SCHEMBL30834002	0.87	NLRP3 (0.38)	NLRP3CCNKCDK7CCNHMNAT1
SCHEMBL30833873	0.84	NLRP3 (0.44)	NLRP3
SCHEMBL30893689	0.84	BTK (0.41)	NLRP3
SCHEMBL30833925	0.84	BTK (0.41)	NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4613749-A1	NLRP3 INFLAMMASOME INHIBITOR AND USE THEREOF	TransThera Sciences (Nanjing), Inc. (CN)	2025-09-10	—	—	EP	disclosed
CN-117986258-A	NLRP3 inflammation corpuscle inhibitor and application thereof	药捷安康(南京)科技股份有限公司	2024-05-07	—	—	CN	disclosed